Net Worth Advisory Group’s Praxis Precision Medicines PRAX Stock Holding History

Net Worth Advisory Group’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$330K	Buy	+1,151	New	+$381K	0.08%	255

Other funds holding PRAX

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Eagle Bay Advisors New York $137M AUM 18.51% 1-Year Est. Return

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Avior Wealth Management Omaha, Nebraska $3.79B AUM 15.36% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Net Worth Advisory Group's PRAX Position: Q3 2026 in Review

Net Worth Advisory Group opened a new position in Praxis Precision Medicines (PRAX) in Q3 2026: 1,151 shares worth $330K. The stake represents 0.08% of the portfolio and ranks #255 among its holdings.

21 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

Net Worth Advisory Group held 1,151 shares of Praxis Precision Medicines worth $330K as of Q3 2026.
Praxis Precision Medicines was a new Net Worth Advisory Group position in Q3 2026.
Praxis Precision Medicines made up 0.08% of Net Worth Advisory Group's portfolio in Q3 2026, its #255 holding.
21 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on Net Worth Advisory Group's 13F filing for Q3 2026, filed 20 Oct 2026.